Donor derived hematopoietic stem cell niche transplantation facilitates mixed chimerism mediated donor specific tolerance

被引:3
|
作者
Zhang, Wensheng [1 ,2 ]
Wang, Yong [1 ,2 ]
Zhong, Fushun [3 ]
Wang, Xinghuan [3 ]
Sucher, Robert [4 ]
Lin, Cheng-Hung [5 ]
Brandacher, Gerald [6 ]
Solari, Mario G. G. [1 ,2 ]
Gorantla, Vijay S. S. [7 ]
Zheng, Xin Xiao [1 ,3 ]
机构
[1] Univ Pittsburgh, Dept Plast Surg, Sch Med, Pittsburgh, PA 15213 USA
[2] Univ Pittsburgh, Thomas E Starzl Transplantat Inst, Sch Med, Pittsburgh, PA USA
[3] Wuhan Univ, Transplantat Med Ctr, Zhongnan Hosp, Wuhan, Hubei, Peoples R China
[4] Univ Hosp Leipzig, Dept Visceral Transplant Thorac & Vasc Surg, Leipzig, Germany
[5] Chang Gung Univ, Chang Gung Mem Hosp, Ctr Vascularized Composite Allotransplantat, Dept Plast & Reconstruct Surg,Coll Med, Tao Yuan, Taiwan
[6] Johns Hopkins Univ, Dept Plast & Reconstruct Surg, Vascularized Composite Allotransplantat Lab, Sch Med, Baltimore, MD USA
[7] Wake Forest Sch Med, Inst Regenerat Med, Dept Surg Ophthalmol & Bioengn, Winston Salem, NC USA
来源
FRONTIERS IN IMMUNOLOGY | 2023年 / 14卷
基金
中国国家自然科学基金;
关键词
tolerance; vascularized composite allotransplantation; mixed chimerism; bone marrow transplantation; hematopoietic stem cell niche; thymic central deletion; BONE-MARROW-TRANSPLANTATION; COSTIMULATORY BLOCKADE; DENDRITIC CELLS; ALLOGRAFT TOLERANCE; CLONAL DELETION; SPLEEN COLONY; ENGRAFTMENT; INDUCTION; LEADS; MAINTENANCE;
D O I
10.3389/fimmu.2023.1093302
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Compelling experimental evidence confirms that the robustness and longevity of mixed chimerism (MC) relies on the persistence and availability of donor-derived hematopoietic stem cell (HSC) niches in recipients. Based on our prior work in rodent vascularized composite allotransplantation (VCA) models, we hypothesize that the vascularized bone components in VCA bearing donor HSC niches, thus may provide a unique biologic opportunity to facilitate stable MC and transplant tolerance. In this study, by utilizing a series of rodent VCA models we demonstrated that donor HSC niches in the vascularized bone facilitate persistent multilineage hematopoietic chimerism in transplant recipients and promote donor-specific tolerance without harsh myeloablation. In addition, the transplanted donor HSC niches in VCA facilitated the donor HSC niches seeding to the recipient bone marrow compartment and contributed to the maintenance and homeostasis of stable MC. Moreover, this study provided evidences that chimeric thymus plays a role in MC-mediated transplant tolerance through a mechanism of thymic central deletion. Mechanistic insights from our study could lead to the use of vascularized donor bone with pre-engrafted HSC niches as a safe, complementary strategy to induce robust and stable MC-mediated tolerance in VCA or solid organ transplantation recipients.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] The Vascularized Bone Marrow Component Is Critical for Donor-Derived Hematopoietic Stem Cell Engraftment, Chimerism and Tolerance in a Murine Hind Limb Transplantation Model
    Ibrahim, Z.
    Lin, C. -H.
    Mao, Q.
    Zhang, W.
    Ng, T.
    Schneeberger, S.
    Zheng, X. X.
    Cooney, D.
    Lee, W. P. A.
    Brandacher, G.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 32 - 33
  • [22] The role of the facilitating cell in the establishment of donor chimerism and transplantation tolerance
    Davenport, C
    Ildstad, ST
    CLINICAL BIOCHEMISTRY, 1998, 31 (05) : 359 - 367
  • [23] DONOR LYMPHOCYTE INFUSIONS FOR MIXED CHIMERISM AFTER HEMATOPOIETIC CELL TRANSPLANTATION IN PEDIATRIC PATIENTS WITH LEUKEMIA
    Barnum, Jessie L.
    Triplett, Brandon
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S90 - S91
  • [24] TOLERANCE INDUCTION BY DONOR CHIMERISM AFTER HEMATOPOIETIC CELL TRANSPLANTATION FROM THE SAME HAPLOIDENTICAL FAMILIAL DONOR IN A LIVER TRANSPLANT RECIPIENT
    Kim, S. -D
    Lee, J. -H
    Lee, Y. -H
    Kim, D-Y
    Choi, Y.
    Lee, S. -G
    Hwang, S.
    Lee, K-H
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S322 - S322
  • [25] Complete donor chimerism following 0/10 HLA-mismatched unrelated donor allogeneic hematopoietic stem cell transplantation
    Camilla Darum Sørensen
    Bjarne Kuno Møller
    Gitte Olesen
    Peter Hokland
    Marianne Hokland
    Bone Marrow Transplantation, 2018, 53 : 1578 - 1582
  • [26] Donor bone marrow transplantation - Chimerism and tolerance
    Delis, S
    Ciancio, G
    Burke, GW
    Garcia-Morales, R
    Miller, J
    TRANSPLANT IMMUNOLOGY, 2004, 13 (02) : 105 - 115
  • [27] Complete donor chimerism following 0/10 HLA-mismatched unrelated donor allogeneic hematopoietic stem cell transplantation
    Sorensen, Camilla Darum
    Moller, Bjarne Kuno
    Olesen, Gitte
    Hokland, Peter
    Hokland, Marianne
    BONE MARROW TRANSPLANTATION, 2018, 53 (12) : 1578 - 1582
  • [28] Donor-Derived Malignancy and Transplantation Morbidity: Risks of Patient and Donor Genetics in Allogeneic Hematopoietic Stem Cell Transplantation
    Williams, Lacey S.
    Williams, Kirsten M.
    Gillis, Nancy
    Bolton, Kelly
    Damm, Frederik
    Deuitch, Natalie T.
    Farhadfar, Nosha
    Gergis, Usama
    Keel, Sioban B.
    Michelis, Fotios, V
    Panch, Sandhya R.
    Porter, Christopher C.
    Sucheston-Campbell, Lara
    Tamari, Roni
    Stefanski, Heather E.
    Godley, Lucy A.
    Lai, Catherine
    TRANSPLANTATION AND CELLULAR THERAPY, 2024, 30 (03): : 255 - 267
  • [29] The use of donor-derived veto cells in hematopoietic stem cell transplantation
    Ophir, Eran
    Reisner, Yair
    FRONTIERS IN IMMUNOLOGY, 2012, 3
  • [30] Donor-Derived Solid Malignancies after Hematopoietic Stem Cell Transplantation
    Hu, Yong-xian
    Cui, Qu
    Liang, Bin
    Huang, He
    ONKOLOGIE, 2010, 33 (04): : 195 - 200